Imipramine, a widely used antidepressant, has rarely been associated with hepatic abnormalities. In the majority of reported cases, hepatic effects have been transient and readily reversible on discontinuation of the drug. We cared for an 11-year-old boy with hepatic failure and massive cell necrosis which followed treatment with imipramine for enuresis. This therapy led to fulminant hepatic failure and subsequent liver transplantation.
No takes yet. Share an insight, caveat, or question.
Shaefer et al. (1990) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: